肺表面活性物质治疗新生儿急性呼吸窘迫综合征25例  

作　　者：胡三红[1] 

机构地区：[1]湖北省武汉市黄陂区人民医院儿科,湖北武汉430300

出　　处：《中国药业》2015年第B11期38-39,共2页China Pharmaceuticals

摘　　要：目的探讨新生儿急性呼吸窘迫综合征（NRDS）的有效临床治疗方法。方法选取医院收治的NRDS患儿50例，将其随机分为对照组和观察组。对照组患者采用常规治疗方案，观察组患者在此基础上加用肺表面活性物质（PS）治疗。观察两组患者的临床治疗效果及并发症、发生情况。结果观察组患儿的治疗总有效率为96．00％，明显高于对照组的84．00％（P〈0．05）；观察组与对照组比较，患儿恢复时间更短，并发症发生率更低（P〈0．05）。结论PS治疗NRDS效果更显著。Objective To explore the effective clinical treatment of acute respiratory distress syndrome in newborns.Methods 50 cases of acute respiratory distress syndrome in our hospital were randomly divided into control group and observation group. The control group with conventional treatment,the observation group based on the use of pulmonary surfactant therapy. To observe the clinical therapeutic effect and complications of two groups of patients.Results The total effective rate of observation group （96.00%） was significantly higher than that of the control group （84%.00） ,the recovery time was shorter,the incidence of complications was lower,and the control group was significantly higher than that of the control group （P〈0.05）,with statistical significance.Conclusion The use of lung showed that the activity of active treatment compared with conventional treatment,the effect is more significant.

关 键 词：新生儿:急性呼吸窘迫综合征:疗效 

分 类 号：R969.4[医药卫生—药理学] R977.6[医药卫生—药学]